Clinical Trials Browser

Phase 2 × Terminated × Thymoma × Clear all

NCT04925947 2024-04-16

A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

Phase 2 Terminated

4 enrolled 10 charts

Thymoma

NCT04469725 2024-03-12

KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma

Phase 2 Terminated

Thymoma

NCT03193437 2023-02-16

SELECT

Phase 2 Terminated

8 enrolled 11 charts

Thymoma

NCT02062632 2019-10-01

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

Phase 2 Terminated

5 enrolled 4 charts

GastrointestinalHead & NeckLymphoidOther solid neoplasmSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lymphoma, Mesothelioma, Sarcoma, Thymoma, Thyroid Neoplasms, Small Cell Lung Carcinoma

NCT01011439 2019-02-06

Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

Phase 2 Terminated

72 enrolled 20 charts

Thymoma

NCT01301391 2019-02-06

Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy

Phase 2 Terminated

30 enrolled 19 charts

Thymoma

NCT00718809 2015-06-10

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Phase 2 Terminated

21 enrolled 13 charts

Thymoma

NCT00818090 2013-04-12

Paclitaxel and Cisplatin for Thymic Neoplasm

Phase 2 Terminated

Thymic epithelial tumor, Thymoma